Ontilyv ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

ontilyv

bial portela & companhia s.a. - opicapone - mal de parkinson - medicamentos contra el parkinson - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.